Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Contiguous deletions involving the 5′ ends of COL4A5 and COL4A6 on Xq22 have been identified in 6 probands from 5 unrelated families presenting with X-linked Alport syndrome and diffuse leiomyomatosis (AS-DL), co-segregating with disease (4 families with initial deletion reports [PMID:7833948]; one additional family [PMID:12784310]). No isolated COL4A6 mutations were detected in a cohort of 250 male patients with hematuria and suspected Alport syndrome, despite screening exons 2, 12–14 of COL4A6 (0/250) (PMID:8738805). These structural variants encompass exon 1 of COL4A6 and extend variably into intron 2 or exon 3 in AS-DL pedigrees (e.g., deletion spanning from intron 2 of COL4A5 to intron 1 of COL4A6) (PMID:26179878; PMID:23958657).
Functional studies demonstrate normal steady-state COL4A6 mRNA levels but absence of α6(IV) protein at the dermal-epidermal junction in XLAS fibroblasts, implicating post-transcriptional loss (PMID:9749944). Proximal promoter analyses revealed a bidirectional regulatory element controlling COL4A5/COL4A6 co-expression, yet direct mechanistic links between COL4A6 disruption and GBM pathology remain unestablished (PMID:11096082). Together, these data support a Limited level of evidence for COL4A6 involvement in Alport syndrome, primarily as part of contiguous gene deletions rather than independent pathogenic variants.
Key take-home: COL4A6 contributes to X-linked Alport syndrome when co-deleted with COL4A5 but lacks independent pathogenic variants in classic AS cohorts, underscoring the diagnostic importance of deletion analysis in patients with AS-DL.
Gene–Disease AssociationLimited6 probands from 5 families with contiguous COL4A5/COL4A6 deletions co-segregating with AS-DL (PMID:7833948; PMID:12784310) and no isolated COL4A6 mutations in 250 patients (PMID:8738805). Genetic EvidenceLimitedContiguous gene deletions involving COL4A6 observed in 6 probands from 5 families (PMID:7833948; PMID:12784310), with no independent COL4A6 variants in a cohort of 250 (PMID:8738805). Functional EvidenceLimitedExpression studies show post-transcriptional absence of alpha6(IV) in XLAS fibroblasts despite normal mRNA (PMID:9749944); promoter analyses defined regulatory elements but pathomechanism remains unclear (PMID:11096082). |